MedPath

Re-evaluation of Etilefrine and Diltiazem combined with Oseltamivir (Tamiflu) in the treatment of seasonal flu.

Phase 1
Conditions
Seasonal Flu due to Influenza A virus.
MedDRA version: 20.0 Level: LLT Classification code 10022002 Term: Influenza A virus infection System Organ Class: 100000015765
Therapeutic area: Diseases [C] - Virus Diseases [C02]
Registration Number
EUCTR2016-004222-42-FR
Lead Sponsor
Centre Hospitalier Régional Universitaire de Lille
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Not specified
Target Recruitment
264
Inclusion Criteria

Patients hospitalized in intensive care units, older than 18
years,
- For a severe flu confirmed by positive PCR on nasopharyngeal
swab
- Whose evolution is less than 96 hours,
- The severity of the flu is assessed by a respiratory failure
defined by the necessity to resort to mechanical ventilation,
invasive or not, or to deliver oxygen with a PaO2/FiO2<200
mmHg.
The inclusion is conditioned to the detection of Influenza A
viruses by rapid detection kit on nasopharyngeal swab.
- Written informed consent from patients or their relatives.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 264
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- No consent.
- Hypersensibility to Oseltamivir.
- Negative rapid detection kit on nasopharyngeal swab.
- Symptoms for more than 96 hours.
- Moribund patients at admission.
- Contraindication to the molecules evaluated.
- Sinusal dysfonction without device.
- Auriculo-ventricular heart block without device.
- Cardiogenic pulmonary oedema.
- Bradycardia<40/min.
- Not treated coronary insufficiency.
- Ventricular arythmia.
- Hyperthryroidism.
- Non controlled hypertension.
- Obstructive cardiomyopathy.
- Heart valve stenosis.
- Pheochromocytoma.
-Concomitant use of beta-blockers, antiarythmic drugs,
especially amiodarone.
- Pregnant/nursing woman
- No social insurance cover
-Patient under a regim of juridic protection

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath